The Use of Technetium-99m for Intravital Tracing of Transplanted Multipotent Stromal Cells


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We studied the possibility of in vivo tracing of multipotent mesenchymal stromal cells labeled with a radiophermaceutic preparation based on metastable isotope Technetium-99m and injected to rats with modeled traumatic brain injury. Accumulation of labeled cells occurred primarily in the liver and lungs. The cells distribution in internal organs greatly varied depending on the administration route. Cell injection into the carotid artery led to their significant accumulation in the damaged brain hemisphere, while intravenous injection was followed by diffuse cell distribution in all brain structures. Scintigraphy data were confirmed by magnetic resonance imaging and histological staining of cells. Visualization of stem cells labeled with Technetium-99m-based preparation by scintigraphy is an objective and highly informative method allowing real-time in vivo cell tracing in the body.

Sobre autores

D. Silachev

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation; A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
Rússia, Moscow; Moscow

A. Kondakov

N. I. Pirogov National Russian Research Medical University, Ministry of Health of the Russian Federation; Hospital for Incurable Patients — Research Medical Rehabilitation Center

Email: zorov@genebee.msu.ru
Rússia, Moscow; Moscow

I. Znamenskii

N. I. Pirogov National Russian Research Medical University, Ministry of Health of the Russian Federation; Hospital for Incurable Patients — Research Medical Rehabilitation Center

Email: zorov@genebee.msu.ru
Rússia, Moscow; Moscow

Yu. Kurashvili

National Research Nuclear University MEPhI; P. A. Hertsen Moscow Oncology Research Institute

Email: zorov@genebee.msu.ru
Rússia, Moscow; Moscow

A. Abolenskaya

P. A. Hertsen Moscow Oncology Research Institute

Email: zorov@genebee.msu.ru
Rússia, Moscow

N. Antipkin

P. A. Hertsen Moscow Oncology Research Institute

Email: zorov@genebee.msu.ru
Rússia, Moscow

T. Danilina

A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
Rússia, Moscow

V. Manskikh

A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
Rússia, Moscow

M. Gulyaev

Laboratory of Magnetic Tomography and Spectroscopy, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
Rússia, Moscow

Yu. Pirogov

Laboratory of Magnetic Tomography and Spectroscopy, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
Rússia, Moscow

E. Plotnikov

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation; A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
Rússia, Moscow; Moscow

D. Zorov

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation; A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Autor responsável pela correspondência
Email: zorov@genebee.msu.ru
Rússia, Moscow; Moscow

G. Sukhikh

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation

Email: zorov@genebee.msu.ru
Rússia, Moscow


Declaração de direitos autorais © Springer Science+Business Media New York, 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies